Skip to content
PubMed This is a summary of 6 peer-reviewed journal articles Updated
Medical Genetics · Dihydrofolate Reductase Deficiency

Navigating a New Diagnosis: Understanding DHFR Deficiency

At a Glance

DHFR deficiency is an extremely rare inherited condition in which the body cannot properly activate folate. It can cause megaloblastic anemia, seizures, and developmental delays, and diagnosis usually relies on genetic testing; specialist care may include folinic acid (leucovorin).

Receiving a diagnosis of DHFR deficiency for your child can feel like being dropped into a world you never knew existed. You may have been told your child has an “ultra-rare” condition, which is a term used for diseases that occur in fewer than one in 50,000 people. In the case of DHFR deficiency, it is even rarer than that.

This page is designed to help you find your footing. While the rarity of this condition is daunting, understanding what is happening in your child’s body is the first step in managing their care.

Understanding the Rarity

As of recent literature reviews, there are only a small number of molecularly confirmed cases of DHFR deficiency documented in medical publications worldwide [1]. Because this number relies on published literature tallies, the true population prevalence is unknown, and some cases may go undiagnosed [1].

Because of this extreme rarity, your local pediatrician or even a general hematologist (blood specialist) may never have seen a case before. Your care will likely be led by a metabolic geneticist—a doctor who specializes in the chemical reactions that keep the body running [1].

What is DHFR Deficiency?

DHFR stands for dihydrofolate reductase. This is an enzyme (a protein that acts as a chemical “helper”) that plays a vital role in how your child’s body uses folate (Vitamin B9) [2].

Think of folate as a raw material the body needs to build DNA and help cells grow. However, the body cannot use raw folate directly; it must be converted into an active form. The DHFR enzyme handles a crucial step in this conversion process [2][1].

  • The Defect: In children with this condition, the DHFR enzyme is missing, structurally unstable, or doesn’t work correctly because of pathogenic changes in the DHFR gene [3].
  • The Result: Without enough active folate, the body struggles to make new cells. This most often affects the bone marrow (leading to megaloblastic anemia) and the brain (contributing to neurological symptoms like seizures or developmental delays) [1].

Genetic Inheritance

This is an autosomal recessive disorder, meaning a child must inherit one non-working gene copy from each parent to be affected [1]. If both parents are carriers, each pregnancy has a 25% (1-in-4) chance of being affected. A genetic counselor can help you understand this and discuss testing options for siblings.

Common Misunderstandings

Because this condition involves folate, it is often confused with more common issues. It is important to clarify these points:

  • It is not “dietary” deficiency: This is not caused by a lack of folate in the diet. Giving your child more folate-rich foods will not fix the underlying metabolic defect [1].
  • Normal blood levels can be misleading: A child can have “normal” levels of standard folate in their blood while their cells are actually starving for the active form they need [1].
  • It is not the same as B12 deficiency: While the anemia looks very similar to Vitamin B12 deficiency, the treatments and underlying causes are fundamentally different [4][1].

The Clinical Journey

Research shows that the “typical” path for this condition is still being mapped out. What we know from the small number of recorded cases is that symptoms often appear in infancy or early childhood [1].

Commonly reported features include:

  1. Megaloblastic Anemia: A condition where the bone marrow produces unusually large, structurally abnormal, and immature red blood cells [1].
  2. Neurological Symptoms: This can include seizures, especially in the newborn period, or delays in reaching developmental milestones [1].
  3. Variable Outcomes: Some children have seen improvements in neurological symptoms with specific treatments, while others have faced more severe challenges, including respiratory complications [1].

What Research Currently Says

There is currently no single, universally agreed-upon “playbook” for treating DHFR deficiency because the patient group is so small. However, the following is generally accepted by experts:

  • Early Genetic Testing is Crucial: Confirming the diagnosis through genetic sequencing is the primary way to secure a diagnosis [1].
  • Monitoring Beyond Anemia: Doctors should monitor more than just blood counts; they often look at metabolic markers like homocysteine or methylmalonic acid (MMA) to see how the body is processing nutrients [5].
  • The Role of Folate Treatment: The form of folate matters immensely. Doctors often use a reduced folate called folinic acid (leucovorin), which can bypass the broken DHFR enzyme, whereas standard over-the-counter folic acid requires DHFR to be processed properly [1].

While the uncertainty of an ultra-rare diagnosis is heavy, you are your child’s most important advocate. By connecting with specialized metabolic centers, you ensure your child benefits from the most current scientific understanding [1][6].

Common questions in this guide

What is DHFR deficiency, and what does it do to a child?
DHFR deficiency is a rare inherited condition caused by changes in the DHFR gene. The body cannot efficiently convert folate into the active form needed to make DNA and new cells, which can affect the bone marrow and brain.
What signs can DHFR deficiency cause in children?
Reported features include megaloblastic anemia, seizures—sometimes beginning in the newborn period—and delays in developmental milestones. Severity varies; some children improve with treatment, while others may have serious neurological or respiratory complications.
How is DHFR deficiency diagnosed?
Genetic sequencing is the main way to confirm DHFR deficiency by identifying pathogenic changes in the DHFR gene. Doctors may also use blood counts and metabolic tests, such as homocysteine or methylmalonic acid, to assess the condition and follow care.
Can a normal folate level rule out DHFR deficiency?
No. Standard blood folate can appear normal even when cells cannot obtain enough active folate, because the problem is the body’s ability to process folate rather than simply how much folate is eaten or circulating.
What treatment is used for DHFR deficiency?
Specialists often consider folinic acid (leucovorin), a reduced form of folate that can bypass the defective DHFR step. There is no single universally agreed treatment plan because so few cases are known, so therapy and monitoring are individualized by a metabolic team.
Is DHFR deficiency inherited, and what is the chance in another pregnancy?
It is autosomal recessive: an affected child inherits one non-working DHFR gene copy from each parent. When both parents are carriers, each pregnancy has a 25% (1-in-4) chance of being affected; a genetic counselor can discuss testing options for future pregnancies and siblings.
Why might a child need a metabolic geneticist for DHFR deficiency?
DHFR deficiency is extremely rare, and many local clinicians may never have managed it. A metabolic geneticist can coordinate specialized diagnosis, folate treatment, and monitoring with hematology and other specialists.

Get notified when new evidence is published on Constitutional megaloblastic anemia with severe neurologic disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (6)
  1. 1

    Identification of novel disease-causing variants and their influence on clinical presentation in dihydrofolate reductase deficiency.

    Wang D, Zhou D, Zhang Y, et al.

    Neuroscience 2025; (583()):84-92 doi:10.1016/j.neuroscience.2025.07.045.

    PMID: 40752814
  2. 2

    DHFR2 RNA directly regulates dihydrofolate reductase and its expression level impacts folate one carbon metabolism.

    Drago P, Bookey N, Leung KY, et al.

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2025; (39(4)):e70391 doi:10.1096/fj.202401039RR.

    PMID: 39957677
  3. 3

    Disease-linked mutations cause exposure of a protein quality control degron.

    Kampmeyer C, Larsen-Ledet S, Wagnkilde MR, et al.

    Structure (London, England : 1993) 2022; (30(9)):1245-1253.e5 doi:10.1016/j.str.2022.05.016.

    PMID: 35700725
  4. 4

    Acquired Vitamin B12 Deficiency in Newborns: Positive Impact on Newborn Health through Early Detection.

    Lipari Pinto P, Florindo C, Janeiro P, et al.

    Nutrients 2022; (14(20)) doi:10.3390/nu14204397.

    PMID: 36297083
  5. 5

    First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders.

    Olivieri G, Bordugo A, Burnyte B, et al.

    Journal of inherited metabolic disease 2026; (49(4)):e70177 doi:10.1002/jimd.70177.

    PMID: 42231716
  6. 6

    Cerebral folate deficiency: Analytical tests and differential diagnosis.

    Pope S, Artuch R, Heales S, Rahman S

    Journal of inherited metabolic disease 2019; (42(4)):655-672 doi:10.1002/jimd.12092.

    PMID: 30916789

This page is for informational purposes only and does not constitute medical advice. Your child’s metabolic geneticist, hematologist, and other specialists should interpret test results and guide treatment.